A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/409 (2006.01) A61K 35/14 (2006.01) A61K 41/00 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2199400
Multiple sclerosis and rheumatoid arthritis can be treated effectively using photodynamic therapy. In this protocol, a photoactive compound is administered, allowed to distribute in the affected subject, and the subject is then irradiated to activate the photoactive compound. Alternatively, the blood of a subject to be treated can be subjected to PDT extracorporeally. In the case of rheumatoid arthritis, localized treatment at the joints may also be employed.
On peut traiter efficacement la sclérose en plaque et la polyarthrite rhumatoïde en utilisant la thérapie photodynamique. Dans ce protocole, on administre un composé photosensible qui se diffuse dans le sujet atteint que l'on irradie ensuite pour activer le composé photosensible. On peut également soumettre de manière extracorporelle le sang du sujet à traiter à une thérapie photodynamique. Dans le cas de la polyarthrite rhumatoïde, on peut également procéder à un traitement localisé au niveau des articulations.
Chan Agnes How-Ching
Hunt David William Carey
Leong Simon
Levy Julia
North Janice
Fetherstonhaugh & Co.
Qlt Inc.
Quadra Logic Technologies Inc.
The University Of British Columbia
LandOfFree
Photodynamic therapy in selective cell inactivation in blood... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Photodynamic therapy in selective cell inactivation in blood..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Photodynamic therapy in selective cell inactivation in blood... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2053300